K2 PRINCIPAL FUND, L.P. - NOVELION THERAPEUTICS INC ownership

NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 71 filers reported holding NOVELION THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
K2 PRINCIPAL FUND, L.P. ownership history of NOVELION THERAPEUTICS INC
ValueSharesWeighting
Q3 2017$632,000
+19.2%
89,900
+82.2%
0.04%
-4.5%
Q1 2017$530,000
-76.7%
49,350
-81.7%
0.04%
-79.4%
Q4 2016$2,270,000269,5360.21%
Other shareholders
NOVELION THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,703,420$2,685,0002.61%
Healthcare Value Capital, LLC 1,400,000$1,015,0001.83%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 581,042$421,0000.06%
KNOTT DAVID M 109,135$79,0000.03%
EdgePoint Investment Group Inc. 3,100,931$2,248,0000.02%
Yakira Capital Management, Inc. 36,428$26,0000.01%
FRANKLIN STREET ADVISORS INC /NC 46,000$33,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 84,353$61,0000.00%
FARMERS & MERCHANTS INVESTMENTS INC 191$00.00%
MILLENNIUM MANAGEMENT LLC 19,814$14,0000.00%
View complete list of NOVELION THERAPEUTICS INC shareholders